News

MS Treatments in Australia: old, new and emerging and how can we better treat the symptoms of MS

10 December 2013

Related News

26 June 2025

The Pharmaceutical Benefits Advisory Committee has recommended ublituximab (Briumvi®) be listed on the PBS for treating relapsing remitting MS….

24 June 2025

CEO Rohan Greenland responds to the latest NDIS pricing decision, warning it threatens access to essential therapies and places additional…
Read More
brain

Newsletter subscription

  • Enter your details

MS Treatments in Australia: old, new and emerging and how can we better treat the symptoms of MS